RLYB (Rallybio Corp.) Margin resik

Simbol resmi perusahaan Rallybio (RLYB)

Rallybio Corporation develops biologics for the treatment of ultra-rare pathologies, securing monopoly revenues through patent protection. This chart on GURU.Markets includes the revenue profitability level, highlighting the flexibility of the clinical trial outsourcing model. Meanwhile, the value of 6177.40 serves as a baseline performance indicator. Business stability is guaranteed by minimal geopolitical pressure within the legal frameworks of the US and EU.

RLYB: Margin resik rallybio.com 04.07.2022 - 20.11.2026

Ringkesan rincian data analitis Rallybio (RLYB)

- nilai pasar lan prakiraan target analis:
- indikator valuasi pasar bisnis:
Analisis komprehensif perusahaan:rallybio.com, RLYB
Barang unggulan rallybio.com

Sales margins determine investment stability, reflecting a business's ability to convert revenue into net profit. This metric is calculated as the ratio of the final financial result to total income. The trend in aggregate sales profitability visualizes the efficiency of cost management. For Rallybio Corporation (RLYB), this indicator is specific, as revenues are generated through grants for the development of drugs for rare pathologies.

Karo sapa Rallybio Corporation saingan

HLN: Margin dodolan resik|Rentabilitas dodolan resik KVUE|Margin resik veronapharma.com|Rentabilitas dodolan resik MENS (Jyong Biotech Corp)|Margin resik Ligand (LGND)|Margin dodolan resik amneal.com (AMRX)|Margin dodolan resik PRGO (perrigo.com)|Alvotech SA (ALVO) - Margin resik|Liquidia Inc. - Margin dodolan resik|Tingkat bathi miturut bathi resik Galapagos Corp (GLPG)|ANI Pharmaceuticals (ANIP) - Margin resik|Rentabilitas dodolan resik MNKD|Margin resik Amphastar Pharmaceuticals, Inc.|Pacira Pharmaceuticals (PCRX) - Margin dodolan perusahaan|Margin dodolan resik SPRY|TBPH - Margin resik|Aquestive Pharma - Rentabilitas dodolan miturut bathi resik|Margin dodolan resik scpharmaceuticals.com SCPH|Tectonic - Margin dodolan resik|TNXP - Margin dodolan resik|SXTC: Margin dodolan resik|Eupraxia Pharma - Tingkat bathi resik|BHST (bioharvest.com) - Margin dodolan resik|Rentabilitas dodolan resik EXOZ (invizyne.com)|Margin dodolan resik ORMP|Margin dodolan perusahaan Entera Bio|Margin dodolan resik HYFT (MindWalk Holdings, Inc.)|ABVC BioPharma - Margin resik|Cumberland Corp - Margin dodolan resik|QNTM - Margin dodolan resik|FibroGen, Inc. (FGEN) - Margin resik|TELO: Rentabilitas resik perusahaan|RANI (Rani Therapeutics Inc) - Margin dodolan resik|Margin resik synergychc.com SNYR|Margin dodolan resik LEXX|PULM (Pulmatrix, Inc.) - Tingkat bathi resik|Pheton Holdings - Rentabilitas dodolan miturut bathi resik|Margin dodolan resik Aptorum Group Limited APM|LYRA: Rentabilitas dodolan miturut bathi resik|IBO: Margin resik|TNFA: Margin dodolan resik|YCBD: Rentabilitas resik perusahaan|Margin resik PainReform Ltd|CYTO (altamiratherapeutics.com) - Rentabilitas resik perusahaan|Margin dodolan resik LIPO|OPTN - Margin resik|Margin resik pieris.com PIRS|Tingkat bathi resik PROC|PTPI - Margin resik|Qilian International Holding (QLI) - Rentabilitas dodolan miturut bathi resik|SLRN: Margin dodolan resik|Rentabilitas dodolan miturut bathi resik TFF Pharma